ICER’s Asthma Report Comes up Short
It’s plagued by incomplete analysis and missing data, yet the Institute for Clinical and Economic Review’s draft evidence report on severe asthma medicine still manages to deliver a familiar refrain. All five of the drugs reviewed, ICER reports, are not cost-effective.
Living with Gout and Chronic Kidney Disease
They cost me a promising college basketball career, my second toe and, for a while, my self-esteem. But gout and chronic kidney disease haven’t stopped me from leading a full life. And they shouldn’t hold others back either.
Task Force Encourages Research Benefitting Pregnant & Breastfeeding Women
Pregnant or breastfeeding women routinely use medication for everything from the common cold to epilepsy.
Poll: Health Plan Delays are “Unreasonable,” Dangerous for Heart Patients
Heart disease patients, providers, caregivers and stakeholders agree: Health plan policies that delay access to life-saving medication are unacceptable.
#CureStigma this Mental Illness Awareness Week
That’s why this Mental Illness Awareness Week carries a bold call to action: #CureStigma.
Eczema Patients and Providers Battle Insurers for Access
Let me share the story of one of my patients who suffers from severe eczema.
Oklahoma Medicaid Embraces Value-Based Contracting
Oklahoma is leading the nation when it comes to innovative drug pricing approaches.
Poll: Voters Want Policy that Limits Non-Medical Switching
Voters want limits on non-medical switching – and they’re looking to legislators for policy solutions.
Colorado Expands Hepatitis C Treatment for Inmates
For inmates in Colorado who have hepatitis C, the wait for treatment is almost over.
Thousands of Arkansas Medicaid Patients Lose Coverage over Work Requirements
In Arkansas, 4,300 fewer people have health insurance through the state’s Medicaid program this week. Another 5,000 could face a similar fate next month. Why? They failed to meet the state’s Medicaid work requirements.
